A Pharmaceutical Analytical and Exploratory Study of Salsaradi Gana Processed with Shilajatu in the Treatment of Madhumeha

Phase 2/3

Not yet recruiting

• Conditions: Type 2 diabetes mellitus without complications. Ayurveda Condition: MADHUMEHAH/KSHAUDRAMEHAH,

• Registration Number: CTRI/2025/05/086942
• Lead Sponsor: Post Graduate Institute of Ayurved Jodhpur Rajasthan

Brief Summary

Ayurveda, an ancient system of health care, is based on the knowledge of the Vedas and uses herbal, mineral/metal, and animal substances for therapeutic purposes. A key aspect of Ayurveda, Rasa Shastra, focuses on herbo-mineral formulations (Rasaushadhies), which are known for their faster effects and longer shelf life due to their fine-particle size, allowing them to target specific cells.

Shilajatu, a significant herbo-mineral medication, is highly valued in Ayurveda for its rejuvenating properties, which help delay aging and promote strength. It is noted for its various beneficial components like rasa, uparasa, parada, ratna, and lauha.

The study explores Shilajatu purified with Triphala kwatha and combined with Salsaradi Gana dravya to treat Madhumeha (diabetes mellitus), a metabolic disorder caused by insulin deficiency, leading to symptoms like high blood sugar and frequent urination. Ayurveda offers alternative therapies to manage Madhumeha, and Salsaradi Gana Bhawit Shilajatu enhances Shilajatu’s potency, offering a promising treatment option for the condition.

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2025-10-05
• Study Start: 2026-02-02

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Patient giving the clinical history of Madhumeha Presence of cardinal symptoms of diabetes mellitus eg 3P Polyuria Polydipsia Polyphagia Patient fasting blood sugar level is 126mg per dl to 200mg per dl and Post Prandial Blood Sugar PPBS level is 200mg per dl to 350mg per dl The fresh diagnosed case of type II DM will include.

Exclusion Criteria

Patients below 30 year and above 65 years will be excluded Pregnant women or the women planning to be pregnant in next 6 month lactating mother CVS disorder CAD CNS disorder eg encephalopathy Patient of type II DM who are on insulin therapy Patient of type I DM.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change In Subjective And Objective Parameter	90 days

Secondary Outcome Measures

Name	Time	Method
Improvement in Quality of life of Patient	90 days

Trial Locations

Locations (1)

Sanjeevani Hospital; 🇮🇳 Jodhpur, RAJASTHAN, India

Sanjeevani Hospital

🇮🇳Jodhpur, RAJASTHAN, India

Dr Mahaveer singh ashiya

Principal investigator

07023232889

mahaveersingh.ashiya@gmail.com